Summary
Cencora, Inc. (formerly AmerisourceBergen Corporation) has announced a significant development through its subsidiary, AmerisourceBergen Drug Corporation (ABDC). On June 13, 2016, ABDC entered into a binding term sheet with Kaiser Foundation Hospitals, a major healthcare provider. This agreement signifies that Kaiser has chosen ABDC to handle its pharmaceutical wholesale distribution business. The term of this new contract is set for five years, commencing on July 1, 2016. This is a material development for Cencora, as securing a long-term contract with a large entity like Kaiser is expected to contribute substantially to its revenue and market position within the pharmaceutical distribution sector. Investors should view this as a positive sign of the company's ability to attract and retain significant clients.
Key Highlights
- 1AmerisourceBergen Drug Corporation (ABDC), a subsidiary of Cencora, Inc., has secured a new pharmaceutical wholesale distribution contract with Kaiser Foundation Hospitals.
- 2The contract is for a duration of five years.
- 3The agreement is set to commence on July 1, 2016.
- 4This represents a significant award of business from a major healthcare provider.
- 5The term sheet is binding, indicating a firm commitment from both parties.
- 6This filing was made on June 14, 2016, with the earliest event reported on June 13, 2016.